Spotted fever rickettsiosis

Spotted fever rickettsiosis is a bacterial disease caused by spotted fever group rickettsiae, with *Rickettsia rickettsii* specifically identified in the provided sources as an etiologic agent ^[1][2]. One source explicitly states that *R. rickettsii* is a tick-borne pathogen responsible for Rocky Mountain Spotted Fever, which is presented in the material as part of the spotted fever rickettsiosis spectrum ^[1]. The available sources also describe these organisms as obligate intracellular rickettsial organisms ^[1].

The source material emphasizes potentially severe disease, including progression to fulminant multiorgan failure and death ^[1]. It also states that rickettsial infections can rapidly become fatal in both healthy and immunosuppressed patients ^[1]. In one reported case, *R. rickettsii* acquired on a camping trip precipitated a flare of peripheral arthritis and episcleritis in an HLA-B27 positive patient ^[1]. Beyond these points, a fuller source-backed description of the routine symptom sequence, complications, or typical duration is not yet available from the provided snippets ^[1].

The available evidence identifies spotted fever rickettsiosis as a tick-borne disease and places it within a broader group of tick-associated infections that create substantial public-health burden worldwide ^[1][2]. One review notes that tick-borne diseases are emerging in association with the geographical expansion of tick vectors, especially in the northern hemisphere ^[2]. The sources also document geographically diverse reports of spotted fever rickettsioses, including fatal cases in Kenya and Argentina and recognition of other spotted fever group agents in travelers and international settings ^[3][4][5]. Source-backed detail on incidence, local endemicity, or population-level surveillance frequency is not yet available from the provided snippets ^[4][3][5][2].

Transmission is described in the sources as tick borne, indicating exposure through tick vectors rather than person-to-person spread ^[1][2]. One case example specifically links acquisition to a camping trip, illustrating outdoor tick exposure as a relevant mechanism in the evidence set ^[1]. No additional source-backed detail is provided here on specific tick species, duration of attachment, or persistence outside the vector ^[1][2].

The provided sources do not define a complete risk-group profile, but they do identify exposure in people with outdoor camping-associated tick contact and in international travelers as relevant contexts ^[1][5]. One case involved an HLA-B27 positive patient whose infection coincided with inflammatory flare features, but this should be read as a case-specific observation rather than a general susceptibility statement ^[1]. The sources also state that rickettsial infections can be rapidly fatal in both healthy and immunosuppressed patients, so no narrow high-risk group can be confirmed from the snippets alone ^[1].

The source snippets support prevention primarily through avoidance of tick exposure in outdoor settings and awareness of travel- or camping-associated risk ^[1][5][2]. Because the disease is vector-borne, public-health attention to tick ecology and the geographical expansion of tick vectors is relevant to prevention planning ^[2]. The provided material does not supply source-backed detail on personal protective measures, prophylaxis, or vaccine use ^[1][2].

For surveillance purposes, spotted fever rickettsiosis should be interpreted as a tick-borne rickettsial infection with potential for rapid deterioration and severe outcomes, including death ^[1]. The literature cited here also highlights diagnostic complexity in rickettsial disease and notes that serology may be only presumptive, with molecular and culture-based methods important for confirmation and for recognizing atypical cases ^[5]. Reports from travelers and from geographically separated fatal cases indicate that surveillance should consider both local vector ecology and imported exposure histories ^[3][5][2].

1. 1 Redford AH et al. HLA-B27 spondyloarthritis and spotted fever rickettsiosis: case-based review. Rheumatol Int. 2019 Sep. PMID: 31134290. doi: 10.1007/s00296-019-04330-8. PubMed: https://pubmed.ncbi.nlm.nih.gov/31134290/
2. 2 Rochlin I et al. Emerging tick-borne pathogens of public health importance: a mini-review. J Med Microbiol. 2020 Jun. PMID: 32478654. doi: 10.1099/jmm.0.001206. PubMed: https://pubmed.ncbi.nlm.nih.gov/32478654/
3. 3 Rolain JM et al. Rickettsial infections--a threat to travellers? Curr Opin Infect Dis. 2004 Oct. PMID: 15353963. doi: 10.1097/00001432-200410000-00008. PubMed: https://pubmed.ncbi.nlm.nih.gov/15353963/
4. 4 Fatal Spotted Fever Rickettsiosis, Kenya. Emerging Infectious Diseases. 2004. doi: 10.3201/eid1005.030537. DOI: https://doi.org/10.3201/eid1005.030537
5. 5 Fatal spotted fever rickettsiosis in Argentina. IDCases. 2018. doi: 10.1016/j.idcr.2018.05.006. DOI: https://doi.org/10.1016/j.idcr.2018.05.006
6. 6 Astrakhan fever, a spotted-fever rickettsiosis. The Lancet. 1991. doi: 10.1016/0140-6736(91)90833-b. DOI: https://doi.org/10.1016/0140-6736(91)90833-b

ICD-10

ICD-11

Total cases

79K

Peak month

2023-08

Coverage

4 reporting countries · 2007-01-01 → 2010-01-02